Globe Life Inc. (NYSE:GL) Given Average Recommendation of “Moderate Buy” by Analysts

Globe Life Inc. (NYSE:GL) has been assigned a consensus recommendation of “Moderate Buy” from the ten research firms that are presently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average twelve-month price target among brokers that have covered the stock in the last year is $171.00.

Several equities analysts recently issued reports on GL shares. Evercore cut Globe Life from an “outperform” rating to an “in-line” rating and set a $155.00 price objective on the stock. in a research note on Tuesday, January 6th. Piper Sandler restated an “overweight” rating and issued a $167.00 target price on shares of Globe Life in a research note on Friday, November 21st. Morgan Stanley reaffirmed an “overweight” rating and set a $176.00 target price on shares of Globe Life in a report on Monday, December 15th. Wells Fargo & Company dropped their price target on Globe Life from $172.00 to $170.00 and set an “overweight” rating on the stock in a research report on Friday, October 24th. Finally, JPMorgan Chase & Co. boosted their price objective on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th.

Globe Life Stock Performance

Shares of GL stock opened at $142.04 on Wednesday. The stock has a market capitalization of $11.31 billion, a price-to-earnings ratio of 10.09 and a beta of 0.47. Globe Life has a one year low of $109.38 and a one year high of $152.71. The company’s 50-day simple moving average is $139.77 and its 200-day simple moving average is $138.29. The company has a debt-to-equity ratio of 0.41, a quick ratio of 0.07 and a current ratio of 0.07.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). Globe Life had a net margin of 19.37% and a return on equity of 21.75%. The firm had revenue of $1.52 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the company earned $3.14 EPS. The company’s quarterly revenue was up 3.6% compared to the same quarter last year. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. Equities analysts anticipate that Globe Life will post 13.87 earnings per share for the current fiscal year.

Insider Activity

In related news, CEO Frank M. Svoboda sold 9,379 shares of Globe Life stock in a transaction dated Tuesday, December 16th. The shares were sold at an average price of $140.43, for a total value of $1,317,092.97. Following the sale, the chief executive officer directly owned 35,868 shares in the company, valued at $5,036,943.24. This trade represents a 20.73% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Michael Clay Majors sold 30,000 shares of the business’s stock in a transaction dated Friday, February 6th. The shares were sold at an average price of $146.89, for a total transaction of $4,406,700.00. Following the transaction, the executive vice president directly owned 47,066 shares of the company’s stock, valued at $6,913,524.74. The trade was a 38.93% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 41,129 shares of company stock valued at $5,982,635. 1.97% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Globe Life

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Transcend Capital Advisors LLC increased its position in Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock valued at $317,000 after acquiring an additional 84 shares during the period. Natural Investments LLC grew its position in Globe Life by 2.6% in the 4th quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock valued at $482,000 after buying an additional 87 shares in the last quarter. Intech Investment Management LLC increased its stake in Globe Life by 0.8% during the 2nd quarter. Intech Investment Management LLC now owns 11,572 shares of the company’s stock valued at $1,438,000 after buying an additional 95 shares during the period. CX Institutional increased its stake in Globe Life by 5.6% during the 3rd quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after buying an additional 96 shares during the period. Finally, Laird Norton Wetherby Wealth Management LLC raised its position in shares of Globe Life by 2.2% during the 3rd quarter. Laird Norton Wetherby Wealth Management LLC now owns 4,518 shares of the company’s stock worth $646,000 after buying an additional 99 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors and hedge funds.

Globe Life Company Profile

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.